TARGET
saveCD20
B-cell antigen; target of rituximab and obinutuzumab.
also known as: ms4a1, b-lymphocyte antigen cd20
drugs
0
catalysts
0
news
6
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?fiercebiotech · 6d ago
- Legend Biotech CEO abruptly steps down without permanent replacementfiercebiotech · 24d ago
- Lilly, AbbVie climb aboard in vivo CAR T train—but safety remains a hurdlebiospace · 25d ago
- Legend surges on early data for ‘in vivo’ lymphoma cell therapybiopharma dive · 2mo ago
- FDA Approves Sonrotoclax for Relapsed/Refractory Mantle Cell Lymphomaonclive · 3mo ago
comments(0)
5-min edit window · permanent after that